145 related articles for article (PubMed ID: 3076139)
21. Effects of pinacidil on the heart: serial electrocardiographic and echocardiographic observations.
Shub C; Zachariah PK; Ilstrup DM; Tajik AJ
Can J Cardiol; 1987; 3(5):223-9. PubMed ID: 3300903
[TBL] [Abstract][Full Text] [Related]
22. Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group.
Fletcher AE; Battersby C; Adnitt P; Underwood N; Jurgensen HJ; Bulpitt CJ
J Cardiovasc Pharmacol; 1992 Jul; 20(1):108-14. PubMed ID: 1383618
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of pinacidil and prazosin on blood pressure, weight, plasma volume, the renin-angiotensin-aldosterone system, and the renal kallikrein-kinin system in patients with essential hypertension.
Solomon RJ; Weinberg MS
J Clin Hypertens; 1987 Dec; 3(4):589-95. PubMed ID: 3330989
[TBL] [Abstract][Full Text] [Related]
24. Preliminary evaluation of pinacidil in hypertension.
Ramsay LE; Freestone S
Br J Clin Pharmacol; 1983 Sep; 16(3):336-8. PubMed ID: 6626426
[TBL] [Abstract][Full Text] [Related]
25. Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension.
Bune AJ; Chalmers JP; Graham JR; Howe PR; West MJ; Wing LM
Eur J Clin Pharmacol; 1981; 19(5):309-15. PubMed ID: 7016550
[No Abstract] [Full Text] [Related]
26. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
[No Abstract] [Full Text] [Related]
27. Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1977 Sep; 14(3):163-97. PubMed ID: 143363
[No Abstract] [Full Text] [Related]
28. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
Rhomberg F; Widler J
Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
[TBL] [Abstract][Full Text] [Related]
29. Comparison of prazosin with hydralazine in patients receiving hydrochlorothiazide. A randomized, double-blind clinical trial.
Circulation; 1981 Oct; 64(4):772-9. PubMed ID: 7023744
[TBL] [Abstract][Full Text] [Related]
30. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
[TBL] [Abstract][Full Text] [Related]
31. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
Whelton PK; Russell RP; Sova-Schulz K; Wyndham R; Walker WG
J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S28-37. PubMed ID: 94637
[TBL] [Abstract][Full Text] [Related]
32. No deterioration of insulin secretion by the potassium channel opener pinacidil in essential hypertension.
Ligtenberg JJ; Leenaers AD; Van Haeften TW; Smit AJ; Sluiter WJ; Reitsma WD
J Hum Hypertens; 1996 Apr; 10(4):269-76. PubMed ID: 8736460
[TBL] [Abstract][Full Text] [Related]
33. Pinacidil monotherapy for hypertension.
Ward JW
Br J Clin Pharmacol; 1984 Aug; 18(2):223-5. PubMed ID: 6487460
[TBL] [Abstract][Full Text] [Related]
34. Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.
Muiesan G; Fariello R; Muiesan ML; Christensen OE
Eur J Clin Pharmacol; 1985; 28(5):495-9. PubMed ID: 3899669
[TBL] [Abstract][Full Text] [Related]
35. Approach to drug therapy for hypertension.
Kuchel OG; Mahon WA; McKenzie JK; Ogilvie RI
Can Med Assoc J; 1979 Mar; 120(5):565-70. PubMed ID: 35278
[TBL] [Abstract][Full Text] [Related]
36. Double-blind studies of the clinical effectiveness of prazosin.
Schnaper HW; Oberman A
Postgrad Med; 1975 Nov; Spec No():81-7. PubMed ID: 1105489
[TBL] [Abstract][Full Text] [Related]
37. Effects of pinacidil on detrusor instability in men with bladder outlet obstruction.
Hedlund H; Mattiasson A; Andersson KE
J Urol; 1991 Nov; 146(5):1345-7. PubMed ID: 1942288
[TBL] [Abstract][Full Text] [Related]
38. Pinacidil, a new vasodilator, in the treatment of patients with moderate to severe hypertension.
Koliopoulos K; Papadoyannis DE; Karatzas NB
Eur J Clin Pharmacol; 1984; 27(3):287-9. PubMed ID: 6510455
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
Fagan TC; Sternleib C; Vlachakis N; Deedwania PC; Mehta JL
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1109-13. PubMed ID: 6085377
[TBL] [Abstract][Full Text] [Related]
40. "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
McAreavey D; Ramsey LE; Latham L; McLaren AD; Lorimer AR; Reid JL; Robertson JI; Robertson MP; Weir RJ
Br Med J (Clin Res Ed); 1984 Jan; 288(6411):106-11. PubMed ID: 6419809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
